(Adnkronos Health) – The transformation of radiology, however, does not only concern technology. The most profound change is represented by the shift from diagnosis to direct treatment of diseases. Interventional radiology, in fact, allows for performing targeted and minimally invasive procedures, often guided by images, often as an alternative to traditional surgery. In selected patients, these approaches can help reduce complications, shorten hospital stays, and promote faster recovery.
“This is an evolution that began almost sixty years ago. Already in 1967, Alexander Margulis had outlined the concept of interventional radiology, anticipating a vision in which the radiologist would not be limited to formulating diagnoses, but would also assume a clinical and therapeutic role,” emphasizes Gianpaolo Carrafiello, director of the Services Area department at the Polyclinic of Milan and full professor of Diagnostic Imaging at the University of Milan. “Today, that perspective has become a consolidated reality in numerous areas of medicine. One of the most significant examples comes from oncology. These procedures are applied especially in certain liver and kidney neoplasms and in specific metastatic locations. In hepatocellular carcinoma, in particular, ablation already represents a consolidated therapeutic option for carefully selected patients – the expert clarifies – The most recent scientific evidence confirms its value and, in specific clinical conditions, documents results comparable to those of surgery. Important results also emerge in the treatment of some small kidney tumors, for which ablative techniques can achieve clinical success rates in the order of 94-96%. However, some limitations remain, mainly related to the size, position, and complexity of the tumor. The choice of the most appropriate strategy must therefore always be shared within a multidisciplinary team. A further research front – Carrafiello points out – concerns the possible integration between interventional radiology and immunotherapy. Some ablative treatments, in addition to directly destroying tumor tissue, can determine modifications of the immune response. Therefore, the possibility that these procedures favor the action of immunotherapeutic drugs, through a synergistic effect, is being studied.”
The Sirm Congress – the note concludes – thus relaunches a message to the Institutions: radiology must be considered a strategic investment for the National Health Service. Its contribution is not measured exclusively by the number of examinations performed, but by its ability to improve diagnoses, guide therapeutic choices, avoid inappropriate procedures, and offer increasingly less invasive treatments.